首頁 > 市場調查報告書 > 製藥

DDS

市場調查報告書

商品編碼

1638774

腸內餵食配方奶粉市場機會、成長促進因素、產業趨勢分析與預測 2024 - 2032 年

Enteral Feeding Formulas Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

出版日期: 2024年11月05日 | 出版商:

Global Market Insights Inc. | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

全球腸內餵食配方奶粉市場將於2023 年達到70 億美元，預計2024 年至2032 年將以7.1% 的複合年成長率成長。口服食物的人）設計的液體營養產品：吞嚥困難、胃腸道疾病或神經系統損傷。這些配方奶粉通常透過飼管施用，將營養物質直接輸送到胃或小腸。

市面上有多種配方，如標準配方、特定疾病配方、元素配方、半元素配方等。標準配方奶粉細分市場佔據最大的市場佔有率，到 2023 年貢獻 36 億美元。這些完整的營養配方易於取得且價格實惠，適用於醫院和家庭護理環境，預計將在未來幾年推動該領域的顯著成長。

該市場也按年齡層別分類，2023年成人細分市場處於領先地位，佔市場總收入的82.2%。這一趨勢主要是由越來越多的老年人推動的，由於與老化相關的各種健康挑戰，他們經常需要腸內餵食。隨著醫療保健系統適應老齡化人口的營養需求，腸內營養的需求預計將繼續成長，進一步推動這一領域的發展。

市場範圍
開始年份	2023年
預測年份	2024-2032
起始值	70 億美元
預測值	129 億美元
複合年成長率	7.1%

依最終用途分類，腸內餵食配方奶粉市場分為醫院、長期照護機構、家庭照護機構和療養院。到 2023 年，醫院領域的價值將達到 32 億美元，在市場成長中發揮關鍵作用。人們越來越認知到適當營養對患者復原的重要性，這促使醫院採用腸內餵食解決方案。眾所周知，腸內營養可以加速癒合、減少併發症並縮短恢復時間，因此在醫院的使用越來越多。

在美國，2023年腸內餵食配方奶粉市值為28億美元，預計預測期內複合年成長率為7.2%。美國市場的特點是產品配方不斷創新，包括無乳糖、無麩質和低殘留的選擇，滿足廣泛的患者需求。美國人口老化是推動需求的一個主要因素，因為老年人經常面臨無法口服飲食的狀況。這種人口趨勢預計將維持腸內餵食配方奶粉市場的長期成長。

產業生態系統分析
產業影響力
- 成長動力
  - 老年人口增加和慢性病盛行率
  - 新生兒和早產兒腸內餵食的需求不斷成長
  - 家庭護理環境中腸內餵食的需求不斷增加
  - 消費特定疾病配方奶粉的趨勢正在轉變
- 產業陷阱與挑戰
  - 腸內餵食相關的高成本
  - 併發症的風險
成長潛力分析
監管環境
技術景觀
- 核心技術
- 鄰近技術
定價分析
- 按地區
- 依產品
消費者行為分析
未來市場趨勢
專利分析
管道分析
臨床試驗情況
差距分析
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
公司矩陣分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按產品分類，2021 - 2032 年

主要趨勢
標準配方
疾病特定配方
元素公式
半基本公式
其他公式

第 6 章：市場估計與預測：按階段，2021 - 2032

主要趨勢
成年人
兒科

第 7 章：市場估計與預測：按應用分類，2021 - 2032

主要趨勢
腫瘤學
胃腸道疾病
神經系統疾病
糖尿病
重症監護
其他應用

第 8 章：市場估計與預測：按最終用途，2021 - 2032 年

主要趨勢
醫院
長期照護設施
家庭護理設置
療養院

第 9 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國

第 10 章：公司簡介

Abbott Laboratories
B. Braun Melsungen AG
Baxter International
Danone SA
Fresenius Kabi
Functional Formularies
Hormel Health Labs
Kate Farms
Medtrition
Meiji Holdings
Nestle
NutriMedical
Real Food Blends
Vegenat Healthcare
Victus

簡介目錄

Product Code: 12131

The Global Enteral Feeding Formulas Market reached USD 7 billion in 2023 and is expected to grow at a CAGR of 7.1% from 2024 to 2032. Enteral feeding formulas are specialized liquid nutrition products designed for individuals who cannot consume food orally due to medical conditions such as swallowing difficulties, gastrointestinal disorders, or neurological impairments. These formulas are typically administered via a feeding tube that delivers nutrients directly to the stomach or small intestine.

The market includes a variety of formulas, such as standard formulas, disease-specific formulas, elemental formulas, semi-elemental formulas, and others. The standard formulas segment held the largest market share, contributing USD 3.6 billion in 2023. Their broad usage across diverse patient populations, along with their cost-effectiveness, makes them a preferred choice. The easy availability and affordability of these complete nutritional formulas, suitable for both hospital and home care settings, are expected to drive significant growth in this segment over the coming years.

The market is also divided by age group, with the adult segment leading in 2023, accounting for 82.2% of the total market revenue. This trend is primarily driven by the increasing number of elderly individuals who often require enteral feeding due to various health challenges associated with aging. As healthcare systems adapt to meet the nutritional needs of an aging population, the demand for enteral nutrition is expected to continue growing, further boosting this segment.

Market Scope
Start Year	2023
Forecast Year	2024-2032
Start Value	$7 Billion
Forecast Value	$12.9 Billion
CAGR	7.1%

By end use, the enteral feeding formula market is segmented into hospitals, long-term care facilities, home care settings, and nursing homes. The hospital segment, valued at USD 3.2 billion in 2023, plays a key role in the market's growth. Increasing awareness about the importance of proper nutrition in patient recovery is driving hospitals to adopt enteral feeding solutions. Enteral nutrition is known to speed up healing, reduce complications, and shorten recovery times, leading to its growing use in hospitals.

In the U.S., the enteral feeding formula market was valued at USD 2.8 billion in 2023, with an anticipated growth rate of 7.2% CAGR during the forecast period. The U.S. market is characterized by continuous innovations in product formulations, including lactose-free, gluten-free, and low-residue options, catering to a wide range of patient needs. The aging population in the U.S. is a major factor driving demand, as older adults often struggle with conditions that prevent them from eating orally. This demographic trend is expected to sustain long-term growth in the enteral feeding formula market.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising geriatric population and chronic disease prevalence
  - 3.2.1.2 Growing demand for neonatal and preterm enteral feeding
  - 3.2.1.3 Increasing demand for enteral feeding in home care settings
  - 3.2.1.4 Shifting trend toward consumption of disease-specific formulas
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High costs associated with enteral feeding
  - 3.2.2.2 Risk of complications
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
- 3.5.1 Core technologies
- 3.5.2 Adjacent technologies
3.6 Pricing analysis
- 3.6.1 By region
- 3.6.2 By product
3.7 Consumer behavior analysis
3.8 Future market trends
3.9 Patent analysis
3.10 Pipeline analysis
3.11 Clinical trial landscape
3.12 Gap analysis
3.13 Porter's analysis
3.14 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Standard formulas
5.3 Disease specific formulas
5.4 Elemental formulas
5.5 Semi-elemental formulas
5.6 Other formulas

Chapter 6 Market Estimates and Forecast, By Stage, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Adults
6.3 Pediatric

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Oncology
7.3 Gastrointestinal diseases
7.4 Neurological disorders
7.5 Diabetes
7.6 Critical care
7.7 Other applications

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Hospitals
8.3 Long term care facilities
8.4 Home care settings
8.5 Nursing homes

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE